345 related articles for article (PubMed ID: 16779741)
1. A mathematical model of hepatitis a transmission in the United States indicates value of universal childhood immunization.
Van Effelterre TP; Zink TK; Hoet BJ; Hausdorff WP; Rosenthal P
Clin Infect Dis; 2006 Jul; 43(2):158-64. PubMed ID: 16779741
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.
Rein DB; Hicks KA; Wirth KE; Billah K; Finelli L; Fiore AE; Hoerger TJ; Bell BP; Armstrong GL
Pediatrics; 2007 Jan; 119(1):e12-21. PubMed ID: 17200237
[TBL] [Abstract][Full Text] [Related]
3. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
[TBL] [Abstract][Full Text] [Related]
4. Universal hepatitis A vaccination in the United States: a call for action.
Lieberman JM; Word BM; Jacobs RJ; Dagan R; Marchant CD
Pediatr Infect Dis J; 2008 Apr; 27(4):287-91. PubMed ID: 18316993
[TBL] [Abstract][Full Text] [Related]
5. Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach.
Dhankhar P; Nwankwo C; Pillsbury M; Lauschke A; Goveia MG; Acosta CJ; Elbasha EH
Value Health; 2015 Jun; 18(4):358-67. PubMed ID: 26091589
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis A: disease burden and current childhood vaccination strategies in the United States.
Koslap-Petraco MB; Shub M; Judelsohn R
J Pediatr Health Care; 2008; 22(1):3-11. PubMed ID: 18174084
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis a vaccination coverage among children aged 24-35 months - United States, 2006 and 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(25):689-94. PubMed ID: 19574951
[TBL] [Abstract][Full Text] [Related]
8. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
[TBL] [Abstract][Full Text] [Related]
9. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP
Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis A vaccination coverage among U.S. children aged 12-23 months - immunization information system sentinel sites, 2006-2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(25):776-9. PubMed ID: 20592688
[TBL] [Abstract][Full Text] [Related]
11. A dynamic model for assessing universal Hepatitis A vaccination in Canada.
Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC
Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis a vaccination coverage among adolescents in the United States.
Dorell CG; Yankey D; Byrd KK; Murphy TV
Pediatrics; 2012 Feb; 129(2):213-21. PubMed ID: 22271690
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis A vaccination coverage among children aged 24-35 months--United States, 2004-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(27):678-81. PubMed ID: 17625495
[TBL] [Abstract][Full Text] [Related]
14. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.
Zhou F; Shefer A; Weinbaum C; McCauley M; Kong Y
Vaccine; 2007 May; 25(18):3581-7. PubMed ID: 17306908
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with hepatitis a vaccination among children 24 to 35 months of age: United States, 2003.
Amon JJ; Darling N; Fiore AE; Bell BP; Barker LE
Pediatrics; 2006 Jan; 117(1):30-3. PubMed ID: 16396857
[TBL] [Abstract][Full Text] [Related]
16. Recommended childhood immunization schedule--United States, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Jan; 50(1):7-10, 19. PubMed ID: 11215789
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
Sartori AM; de Soárez PC; Novaes HM; Amaku M; de Azevedo RS; Moreira RC; Pereira LM; Ximenes RA; Martelli CM
Vaccine; 2012 Dec; 30(52):7489-97. PubMed ID: 23107593
[TBL] [Abstract][Full Text] [Related]
18. Cost-utility of universal hepatitis A vaccination in Canada.
Bauch CT; Anonychuk AM; Pham BZ; Gilca V; Duval B; Krahn MD
Vaccine; 2007 Dec; 25(51):8536-48. PubMed ID: 17996339
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy.
Thornley S; Bullen C; Roberts M
J Theor Biol; 2008 Oct; 254(3):599-603. PubMed ID: 18644385
[TBL] [Abstract][Full Text] [Related]
20. Updated recommendations from the Advisory Committee on Immunization Practices (ACIP) for use of hepatitis A vaccine in close contacts of newly arriving international adoptees.
;
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):1006-7. PubMed ID: 19763077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
